Clinical Trial Update: Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial examining whether L-carnitine can prevent heart damage in breast cancer patients undergoing anthracycline chemotherapy; the study has terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Heart Failure | Phase 2, Phase 3 | Status: TERMINATED